BCHE and Alzheimer disease: Cholinesterase inhibitors improve cognitive function (Birks, 2006), while the effectiveness of NMDA receptor antagonists for AD is uncertain (Reisberg et al., 2003; Tariot et al., 2004; Schneider et al., 2011; Howard et al., 2012).